Spot-on therapeutic progress
The world’s first plasma jet for the medical application of tissue-compatible cold plasma
The kINPen® MED product is the first CE-marked plasma jet with a class IIa medical device approval for the treatment of chronic wounds and pathogen-induced skin disorders.
The revolutionary technology of the kINPen® MED plasma jet ensures a consistent plasma quality and a controlled treatment process. Physical cold plasma is applied to the wound at a temperature of < 39° Celsius with pinpoint precision and without direct contact, even in the case of complex wounds and wound environments with recesses and cavities. The effect may extend even to chronic wounds that are beyond treatment, which makes it potentially suitable for the prevention of possible amputations. The treatment range of the therapy comprises multi-resistant pathogens such as MRSA and functional wound healing cells.
(?? Fehlt?)
Application:
User-friendly and safe application
The kINPen® MED plasma jet is very user-friendly, supporting a mobile application in treatment rooms. The treatment is performed by the doctor or trained medical staff. The plasma jet is guided vertically over the wound area at a moderate and constant pace of ca. 5 mm/s. The effective area of the plasma covers about 1 cm2. The gas flow is adjusted on the device and should be 5.0 l/min.
During the treatment an exchangeable (sterile single use) spacer ensures hygiene and the maintenance of the specified distance. The treatment intensity is controlled via the treatment duration. The treatment time should be 30 to 60 s/cm2. The plasma generates an anti-bacterial, anti-mycotic and anti-viral effect on the surface hit by the plasma beam and promotes tissue regeneration.
